|Day Low/High||3.98 / 4.33|
|52 Wk Low/High||4.01 / 26.73|
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Here are some random thoughts and observations from what I saw and heard this morning. Totally off the cuff stuff on Celgene, InterMune, Alnylam, NPS Pharma and Seattle Genetics.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Conference Call at 4:30 pm Eastern Time Today
Upgrades: ACM, BZH, DECK, KT, PPP, RMTI, TKMR Downgrades: AMED, COR, ESC, INWK, IRBT, MGPI, MX, NL, OPLK, PERI, RMCF, RRMS, SYPR, UNAM, VNR Initiations: SHOS Read on to get TheStreet Quant Ratings' detailed report:
Phase II Data Presented at Scientific Symposium Further Validates Tekmira's LNP Technology
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.